Novonail Solution

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Novonail Solution
Generic name: TOLNAFTATE 1%
Manufacturer: Derma Care Research Labs, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 013d6107-e3b0-0264-e063-6394a90ae1e2
SPL ID: 29a5ffca-4dec-43b3-e063-6294a90ac3df
Version: 2
Effective date: 2024-12-19
Source export date: 2026-09-28
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9839785a692b692224cd5f90f9e3a9514c9923a6f521ab83eed3bedc7c0e1d05/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:33:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Novonail Solution	openfda.brand_name
generic name		TOLNAFTATE 1%	openfda.generic_name
manufacturer name		Derma Care Research Labs, LLC	openfda.manufacturer_name
ndc	package	72839-507-01	openfda.package_ndc
ndc	product	72839-507	openfda.product_ndc
ndc11	package	72839050701	derived:openfda.package_ndc
rxcui		313423	openfda.rxcui
spl id		29a5ffca-4dec-43b3-e063-6294a90ac3df	id
spl set id		013d6107-e3b0-0264-e063-6394a90ae1e2	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with eyes. Stop use and ask a doctor if: irritation occurs, there is no improvement within 4 weeks (for athlete's foot and ringworm).

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.